News

Thank you for attending our ASL-Dinner in Toronto, each and every one of you made it a great evening. In case you missed the presentation video, find it below. We are proud and happy to be an integral part of the #ismrm. The annual meeting offered again an interesting exchange on the latest trends in MR imaging.

Have you read one of the latest publications on iron rim lesions in multiple sclerosis by our research partners at the Universitätsmedizin Mannheim? The authors around Prof. Achim Gass conclude that iron rim lesions are associated with higher intrathecal immunoglobin G synthesis. Furthermore, CSF-mediated intrathecal smouldering inflammation could explain a CSF-related gradient of tissue damage.
Read the publication here.

Thank you for having us at the BosomShield kick off meeting. BosomShield is a project aiming a computer-aided design system for breast cancer classification and prognosis of relapse.
If you want to know further information about this project, visit bosomshield.eu.

Did you know that today is world clinical trials day? And did you know that mediri is working constantly to improve standardization of Arterial Spin Labeling MR Imaging for clinical trials? In the ASPIRE project (aspire-mri.eu) we are developing a web platform for easy and manufacturer independent analysis of ASL images for dementia diagnosis.
Want know more about this topic? Join us on ISMRM 2023 in Toronto and come to the ASL Dinner which is hosted by mediri GmbH and Gold Standard Phantoms.

Have you ever thought about assessing cerebral perfusion non-invasively in your next clinical trial? If so, this recently published review paper will address the most important questions such as how to equalize data acquisition across sites, how to perform QC and process the data. 
Read more here: https://lnkd.in/gE3Z8BKT

The implementation of ASL MRI for disease specific clinical cases has taken another milestone. Early 2023, a position paper supported by the ISMRM Perfusion Study Group updated and expanded the ASL MRI consensus paper from 2015 and provides guidance on using ASL MRI for clinical scenarios such as acute ischemic stroke, brain tumors and neurodegenerative diseases. 
Click here to read: https://lnkd.in/dvd7BCCv

ASL perfusion MRI permits non-invasive quantification of cerebral blood flow. The 2015 consensus paper on recommended implementation of ASL MRI established general guidelines for more comparable data acquisition and reproducible research. Mediri is happy to be part of this exciting journey.
Read more here: https://lnkd.in/eFXeQmi2

After a successful member audit we are excited to be a part of the Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA). We are looking forward to our first general meeting in Cologne and the networking opportunities.
Want to know more about BVMA? Click here: https://www.bvma.de/

We proudly announce that the ASPIRE team has a new member: Darmstadt University of Applied Sciences joins the consortium and brings in expertise for AI-based brain image analysis and atlas creation. Together we will establish a platform independent dementia diagnosis support based on arterial spin labeling images.

We proudly announce the release of our new mTRIAL version. For the first time it incorporates a webbased comprehensive DICOM image viewer for platform independent and real time access of clinical trial data. Central read workflow planning and execution has been upgraded for even more reliable and efficient review of radiological data. mTRIAL 3.4. – ready to support your next image based clinical trial.